Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy
Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy
www.nature.com Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy - Nature
Type 1 regulatory T cells (Tr1) represent a major obstacle that compromises naturally occurring and therapeutically induced tumour-specific immunity.
![Neoantigen-specific cytotoxic Tr1 CD4 T cells suppress cancer immunotherapy - Nature](https://rss.ponder.cat/pictrs/image/69805e12-67c0-4c2f-8542-6ccf1b7cdfbf.png?format=webp&thumbnail=256)
0
comments